• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[外泌体靶向适配体筛选技术的进展]

[Advances in exosome-targeting aptamer-screening techniques].

作者信息

Zheng Li-Ting, Yang Ge, Qu Feng

机构信息

School of Life Science, Beijing Institute of Technology, Beijing 100081, China.

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

出版信息

Se Pu. 2025 May;43(5):424-433. doi: 10.3724/SP.J.1123.2024.10029.

DOI:10.3724/SP.J.1123.2024.10029
PMID:40331607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12059990/
Abstract

Exosomes play crucial intercellular-communication roles and regulate various cellular physiological processes. They are considered potential biomarkers for the early diagnosis of cancers and other diseases. Therefore, detecting and isolating exosomes with specific functions has significant clinical implications. Moreover, the development of low-cost, highly sensitive recognition elements for identifying exosomes is essential for advancing early disease diagnosis and treatment. Nucleic acid aptamers are single-stranded DNA or RNA molecules capable of specifically binding to targets and are produced through the systematic evolution of ligands by exponential enrichment (SELEX) technique. Such aptamers are highly stable, chemically synthesizable, exhibit high affinities and specificities, and are applicable to a broad range of targets, which endow them with unique advantages. Currently, aptamers that target exosomes have been used in a variety of research fields, including cell imaging, drug delivery, and disease diagnosis and treatment. However, selecting aptamers that precisely identify specific exosomes is significantly challenging owing to the complex structures of exosome and their heterogeneity. Consequently, obtaining high-performance aptamers requires efficient screening techniques. This review first summarizes the functions and selection strategies of key targets for exosome-aptamer screening. Furthermore, it outlines the main methods and techniques currently used to screen exosome aptamers, which includes five screening techniques: magnetic bead-SELEX, microfluidic-SELEX, nitrocellulose-SELEX, cell-SELEX, and capillary electrophoresis-SELEX. The separation principles, advantages, limitations, and the latest applications of these techniques are discussed in detail. The review finally addresses current challenges associated with selecting exosome aptamers and provides insight into future research directions.

摘要

外泌体在细胞间通讯中发挥着关键作用,并调节各种细胞生理过程。它们被认为是癌症和其他疾病早期诊断的潜在生物标志物。因此,检测和分离具有特定功能的外泌体具有重要的临床意义。此外,开发用于识别外泌体的低成本、高灵敏度识别元件对于推进疾病的早期诊断和治疗至关重要。核酸适体是能够特异性结合靶标的单链DNA或RNA分子,通过指数富集配体系统进化(SELEX)技术产生。这类适体高度稳定、可化学合成,具有高亲和力和特异性,适用于广泛的靶标,这赋予了它们独特的优势。目前,靶向外泌体的适体已被应用于包括细胞成像、药物递送以及疾病诊断和治疗在内的各种研究领域。然而,由于外泌体的复杂结构及其异质性,选择能够精确识别特定外泌体的适体具有重大挑战性。因此,获得高性能适体需要高效的筛选技术。本综述首先总结了外泌体适体筛选关键靶标的功能和选择策略。此外,还概述了目前用于筛选外泌体适体的主要方法和技术,包括五种筛选技术:磁珠SELEX、微流控SELEX、硝酸纤维素SELEX、细胞SELEX和毛细管电泳SELEX。详细讨论了这些技术的分离原理、优点、局限性及最新应用。综述最后探讨了当前选择外泌体适体所面临的挑战,并对未来的研究方向提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3036/12059990/a21d60f06768/img_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3036/12059990/a21d60f06768/img_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3036/12059990/a21d60f06768/img_1.jpg

相似文献

1
[Advances in exosome-targeting aptamer-screening techniques].[外泌体靶向适配体筛选技术的进展]
Se Pu. 2025 May;43(5):424-433. doi: 10.3724/SP.J.1123.2024.10029.
2
[Research advances in non-immobilized aptamer screening techniques for small-molecule targets].[小分子靶标非固定化适配体筛选技术的研究进展]
Se Pu. 2025 Apr 8;43(4):297-308. doi: 10.3724/SP.J.1123.2024.04012.
3
Selection of aptamers targeting small molecules by capillary electrophoresis: Advances, challenges, and prospects.通过毛细管电泳筛选靶向小分子的适配体:进展、挑战与前景
Biotechnol Adv. 2025 Jan-Feb;78:108491. doi: 10.1016/j.biotechadv.2024.108491. Epub 2024 Nov 26.
4
Three-step evolutionary enhanced capillary electrophoresis-SELEX for aptamer selection of exosome vesicles.三步进化增强毛细管电泳-SELEX 用于外泌体囊泡的适体选择。
Talanta. 2024 Jan 15;267:125203. doi: 10.1016/j.talanta.2023.125203. Epub 2023 Sep 14.
5
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.细胞特异性适体的开发:最新进展及选择程序的见解。
Molecules. 2017 Nov 27;22(12):2070. doi: 10.3390/molecules22122070.
6
Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer.全细胞 SELEX 筛选技术的研究进展及其在细胞靶向适配体中的应用。
Mol Biol Rep. 2022 Aug;49(8):7979-7993. doi: 10.1007/s11033-022-07317-0. Epub 2022 Mar 10.
7
Recent progress of SELEX methods for screening nucleic acid aptamers.SELEX 方法筛选核酸适体的最新进展。
Talanta. 2024 Jan 1;266(Pt 1):124998. doi: 10.1016/j.talanta.2023.124998. Epub 2023 Jul 26.
8
Development of a CD63 Aptamer for Efficient Cancer Immunochemistry and Immunoaffinity-Based Exosome Isolation.开发用于高效癌症免疫化学和基于免疫亲和的外泌体分离的 CD63 Aptamer。
Molecules. 2020 Nov 27;25(23):5585. doi: 10.3390/molecules25235585.
9
[Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].[通过毛细管电泳高效筛选8-氧代鸟嘌呤DNA糖基化酶结合适体]
Se Pu. 2021 Jul 8;39(7):721-729. doi: 10.3724/SP.J.1123.2020.12017.
10
SELEX methods on the road to protein targeting with nucleic acid aptamers.SELEX 方法在利用核酸适体进行蛋白质靶向中的应用。
Biochimie. 2018 Nov;154:132-155. doi: 10.1016/j.biochi.2018.09.001. Epub 2018 Sep 5.

本文引用的文献

1
The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients.肝细胞癌患者血清外泌体中合胞素-1的表达及临床意义
Open Life Sci. 2024 Sep 19;19(1):20220930. doi: 10.1515/biol-2022-0930. eCollection 2024.
2
Assessing the Sensitivity of Nested PCR Followed by Direct Sequencing on Exosomal DNA for EGFR Mutation Detection in NSCL.评估巢式 PCR 联合直接测序法检测 NSCLC 患者外显子 DNA 中 EGFR 基因突变的灵敏度。
Iran Biomed J. 2024 Jul 1;28(4):208-15. doi: 10.61186/ibj.4289.
3
Exosomal Serum Biomarkers as Predictors for Laryngeal Carcinoma.
外泌体血清生物标志物作为喉癌的预测指标
Cancers (Basel). 2024 May 27;16(11):2028. doi: 10.3390/cancers16112028.
4
Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal biomarkers.深度学习辅助监测曲妥珠单抗在 HER2 过表达乳腺癌中的疗效:基于肿瘤衍生尿液外泌体生物标志物的 SERS 免疫分析。
Biosens Bioelectron. 2024 Aug 15;258:116347. doi: 10.1016/j.bios.2024.116347. Epub 2024 May 1.
5
Cancer diagnosis using label-free SERS-based exosome analysis.基于无标记 SERS 的外泌体分析用于癌症诊断。
Theranostics. 2024 Feb 24;14(5):1966-1981. doi: 10.7150/thno.92621. eCollection 2024.
6
Aptamer inhibitor selection of SpyCas9 through CE-SELEX.通过 CE-SELEX 对 SpyCas9 进行适体抑制剂选择。
Talanta. 2024 Jun 1;273:125837. doi: 10.1016/j.talanta.2024.125837. Epub 2024 Mar 2.
7
Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes.可推广的锚定适体策略,用于将核酸治疗药物加载到外泌体上。
EMBO Mol Med. 2024 Apr;16(4):1027-1045. doi: 10.1038/s44321-024-00049-7. Epub 2024 Mar 6.
8
Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity.针对严重急性呼吸综合征冠状病毒 2 核衣壳蛋白的适体表现出潜在的抗泛冠状病毒活性。
Signal Transduct Target Ther. 2024 Feb 14;9(1):40. doi: 10.1038/s41392-024-01748-w.
9
One-step and label-free ratiometric fluorescence assay for the detection of plasma exosome towards cancer diagnosis.用于癌症诊断的一步法无标记比率荧光法检测血浆外泌体
Talanta. 2024 May 1;271:125700. doi: 10.1016/j.talanta.2024.125700. Epub 2024 Jan 26.
10
Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a.外泌体生物标志物在卵巢肿瘤鉴别诊断中的作用:CA125、HE4 和 C5a 的新作用。
J Ovarian Res. 2024 Jan 5;17(1):4. doi: 10.1186/s13048-023-01336-6.